Clinical Decision Rule for Excluding Shoulder Fractures (SFER)
Development and External Validation of a Clinical Decision Rule for Excluding Shoulder Fractures: A Prospective Multicentre Diagnostic Accuracy and Cost-Effectiveness Study (SFER Study)
研究概览
详细说明
研究类型
注册 (估计的)
联系人和位置
学习联系方式
- 姓名:Ahmed Samir, BPT
- 电话号码:+201158440335
- 邮箱:dr.ahmedsamer@icloud.com
学习地点
-
-
-
Cairo、埃及
- El - Helal Hospital
-
接触:
- Ahmed Samir, BPT
- 电话号码:201158440335
- 邮箱:dr.ahmedsamer@icloud.com
-
-
参与标准
资格标准
适合学习的年龄
- 成人
- 年长者
接受健康志愿者
取样方法
研究人群
Adult patients aged 18 years or older presenting with acute shoulder trauma within 7 days of injury will be eligible for inclusion
- Patients with polytrauma, previous shoulder surgery, open fractures, or inability to cooperate with clinical assessment will be excluded.
描述
Inclusion Criteria:
- Adult patients aged 18 years or older presenting with acute shoulder trauma within 7 days of injury will be eligible for inclusion
Exclusion Criteria:
- Patients with polytrauma, previous shoulder surgery, open fractures, or inability to cooperate with clinical assessment will be excluded.
学习计划
研究是如何设计的?
设计细节
队列和干预
团体/队列 |
干预/治疗 |
|---|---|
|
Clinical Decision Rule
All participants will undergo standardized assessment using the SFER clinical decision rule
|
All participants will undergo assessment using a structured clinical decision framework designed to stratify patients with acute shoulder trauma into high- and low-risk categories for fracture. In the initial stage, patients will be screened for high-risk features based on demographic factors, symptom severity, and mechanism of injury. Individuals meeting any high-risk criteria will be referred for immediate radiographic evaluation. Patients not classified as high-risk will proceed to a secondary functional assessment stage. This stage incorporates a series of standardized clinical tests evaluating range of motion, localized tenderness, functional loading capacity, and soft tissue signs. Fracture will be considered unlikely only when all functional criteria are within normal limits. Radiographic imaging will be indicated if any abnormal finding is identified during assessment. All variables will be predefined and recorded using standardized criteria to ensure reproducibility and minim
Radiographic imaging (X-ray) will be performed for all participants and will serve as the reference standard for fracture diagnosis.
Radiographs will be interpreted by qualified radiologists who will be blinded to the results of the clinical assessment to reduce diagnostic bias.
|
研究衡量的是什么?
主要结果指标
结果测量 |
大体时间 |
|---|---|
|
Sensitivity
大体时间:through study completion, an average of 6 months
|
through study completion, an average of 6 months
|
|
Senstivity
大体时间:through study completion, an average of 6 months
|
through study completion, an average of 6 months
|
合作者和调查者
研究记录日期
研究主要日期
学习开始 (估计的)
初级完成 (估计的)
研究完成 (估计的)
研究注册日期
首次提交
首先提交符合 QC 标准的
首次发布 (实际的)
研究记录更新
最后更新发布 (实际的)
上次提交的符合 QC 标准的更新
最后验证
更多信息
与本研究相关的术语
其他研究编号
- SFERStudy
计划个人参与者数据 (IPD)
计划共享个人参与者数据 (IPD)?
药物和器械信息、研究文件
研究美国 FDA 监管的药品
研究美国 FDA 监管的设备产品
此信息直接从 clinicaltrials.gov 网站检索,没有任何更改。如果您有任何更改、删除或更新研究详细信息的请求,请联系 register@clinicaltrials.gov. clinicaltrials.gov 上实施更改,我们的网站上也会自动更新.